Phase-2 trial: A three-drug regimen clears coronavirus in seven days
A phase-2 trial found that COVID-19 patients with mild to moderate illness had no detectable virus seven days after treatment
Read MoreA phase-2 trial found that COVID-19 patients with mild to moderate illness had no detectable virus seven days after treatment
Read MoreFor the second time, researchers have been able to clear HIV virus from the body (remission) by transplanting stem cells
Read MoreA 23-year-old pregnant woman in Tamil Nadu tested positive for HIV after receiving a unit of blood at a government
Read MoreThe HIV drug elvitegravir shows significant inhibition in binding and cleavage of human DNA thereby causing distinct impairment of the immune system
Read MoreTwo years after the World Health Organisation recommended that antiretroviral therapy (ART) be initiated in people living with HIV irrespective
Read MoreWith the World Health Organisation releasing guidelines on HIV self-testing, a major obstacle in improving access to diagnosis has been
Read MoreOn June 21, the National Institutes of Health gave permission for starting the first ever clinical trial using CRISPR genome-editing
Read MoreThe global burden and mortality from HIV/AIDS, TB and malaria across the world, and in the developing countries in particular,
Read MoreThe OraQuick In-Home HIV Test was recently approved by the FDA advisory committee for sale over the counter.
Read MorePublished in The Hindu on November 15, 2011 If discrimination against people infected with HIV continues to be a major
Read MorePublished in The Hindu on September 24, 2011 The search for an effective AIDS vaccine began a quarter-century ago and
Read MorePublished in The Hindu on September 12, 2011 The final results of the Phase I prime-boost AIDS (Acquired Immune Deficiency
Read MorePublished in The Hindu on May 2, 2011 Why has the incidence of tuberculosis in India remained around 170 per
Read More